Bleeding recurrence risk among hospitalized patients undergoing therapeutic plasma exchange: a multi-center study.

IF 2.4 3区 医学 Q2 HEMATOLOGY
Blood Transfusion Pub Date : 2024-09-01 Epub Date: 2024-07-19 DOI:10.2450/BloodTransfus.722
Alexandre Soares Ferreira Junior, Morgana Pinheiro Maux Lessa, Kate Sanborn, Alexander Gordee, Maragatha Kuchibhatla, Matthew S Karafin, Oluwatoyosi A Onwuemene
{"title":"Bleeding recurrence risk among hospitalized patients undergoing therapeutic plasma exchange: a multi-center study.","authors":"Alexandre Soares Ferreira Junior, Morgana Pinheiro Maux Lessa, Kate Sanborn, Alexander Gordee, Maragatha Kuchibhatla, Matthew S Karafin, Oluwatoyosi A Onwuemene","doi":"10.2450/BloodTransfus.722","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In hospitalized patients undergoing therapeutic plasma exchange (TPE), it is not known how TPE-associated bleeding risk is impacted by a prior bleeding episode. Therefore, to assess the prevalence and predictors of bleeding recurrence, we analyzed data from the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).</p><p><strong>Materials and methods: </strong>Using a retrospective cross-sectional analysis of REDS-III public use files, we identified hospitalized adults who had a major bleeding episode prior to their first TPE procedure. Patients were classified into two cohorts based on bleeding recurrence (no-recurrence vs recurrence). After identifying potential predictors, we used multiple imputation by chained equations to impute variables with <30% missing data. Variable selection was optimized using a 10-fold cross validated least absolute shrinkage and selection operator. Final predictors were identified by fitting a logistic regression model.</p><p><strong>Results: </strong>In 310 patients with major bleeding prior to TPE initiation, bleeding recurred in 121 (39.0%). We identified the following seven unique predictors: 1) >10 TPE procedures (OR 2.23); 2) intensive care unit stay (OR 1.35); 3) thrombocytopenia (OR 1.26); 4) surgery (OR 1.22); 5) hepatic disease (OR 1.21); 6) 6-10 TPE procedures (OR 1.04); and 7) Asian race (OR 1.01). We also identified the following five interactions: 1) surgery and therapeutic anticoagulation (OR 1.50); 2) 6-10 TPE procedures and therapeutic anticoagulation (OR 1.05); 3) 6-10 TPE procedures and antiplatelets (OR 1.02); 4) >10 TPE procedures and antiplatelets (OR 1.00); and 5) albumin-only TPE and antiplatelets (OR 0.53). When assessed for adjusted performance, the prediction model had a C-statistic of 0.617 (95% CI 0.613-0.619) and Brier Score of 0.342 (95% CI 0.340-0.347).</p><p><strong>Discussion: </strong>In this study assessing predictors of bleeding recurrence among hospitalized patients undergoing TPE, we identified seven variables and five interactions. These findings should be validated in future studies.</p>","PeriodicalId":49260,"journal":{"name":"Blood Transfusion","volume":" ","pages":"420-428"},"PeriodicalIF":2.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390607/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Transfusion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2450/BloodTransfus.722","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In hospitalized patients undergoing therapeutic plasma exchange (TPE), it is not known how TPE-associated bleeding risk is impacted by a prior bleeding episode. Therefore, to assess the prevalence and predictors of bleeding recurrence, we analyzed data from the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Materials and methods: Using a retrospective cross-sectional analysis of REDS-III public use files, we identified hospitalized adults who had a major bleeding episode prior to their first TPE procedure. Patients were classified into two cohorts based on bleeding recurrence (no-recurrence vs recurrence). After identifying potential predictors, we used multiple imputation by chained equations to impute variables with <30% missing data. Variable selection was optimized using a 10-fold cross validated least absolute shrinkage and selection operator. Final predictors were identified by fitting a logistic regression model.

Results: In 310 patients with major bleeding prior to TPE initiation, bleeding recurred in 121 (39.0%). We identified the following seven unique predictors: 1) >10 TPE procedures (OR 2.23); 2) intensive care unit stay (OR 1.35); 3) thrombocytopenia (OR 1.26); 4) surgery (OR 1.22); 5) hepatic disease (OR 1.21); 6) 6-10 TPE procedures (OR 1.04); and 7) Asian race (OR 1.01). We also identified the following five interactions: 1) surgery and therapeutic anticoagulation (OR 1.50); 2) 6-10 TPE procedures and therapeutic anticoagulation (OR 1.05); 3) 6-10 TPE procedures and antiplatelets (OR 1.02); 4) >10 TPE procedures and antiplatelets (OR 1.00); and 5) albumin-only TPE and antiplatelets (OR 0.53). When assessed for adjusted performance, the prediction model had a C-statistic of 0.617 (95% CI 0.613-0.619) and Brier Score of 0.342 (95% CI 0.340-0.347).

Discussion: In this study assessing predictors of bleeding recurrence among hospitalized patients undergoing TPE, we identified seven variables and five interactions. These findings should be validated in future studies.

接受治疗性血浆置换的住院患者的出血复发风险:一项多中心研究。
背景:在接受治疗性血浆置换(TPE)的住院患者中,TPE相关的出血风险如何受到之前出血事件的影响尚不清楚。因此,为了评估出血复发的发生率和预测因素,我们分析了受者流行病学和捐献者评估研究-III(REDS-III)的数据:通过对 REDS-III 公共使用档案进行回顾性横断面分析,我们确定了在首次接受 TPE 手术前发生过大出血的住院成人。根据出血复发情况将患者分为两组(未复发与复发)。在确定了潜在的预测因素后,我们通过链式方程使用多重估算法对变量进行了估算:在开始使用 TPE 之前发生大出血的 310 例患者中,有 121 例(39.0%)复发。我们确定了以下七个独特的预测因素:1)>10 次 TPE 手术(OR 2.23);2)重症监护室住院(OR 1.35);3)血小板减少(OR 1.26);4)手术(OR 1.22);5)肝病(OR 1.21);6)6-10 次 TPE 手术(OR 1.04);7)亚洲人种(OR 1.01)。我们还发现了以下五种交互作用:1)手术和治疗性抗凝(OR 1.50);2)6-10 次 TPE 手术和治疗性抗凝(OR 1.05);3)6-10 次 TPE 手术和抗血小板(OR 1.02);4)>10 次 TPE 手术和抗血小板(OR 1.00);5)纯白蛋白 TPE 和抗血小板(OR 0.53)。在评估调整后的性能时,预测模型的C统计量为0.617(95% CI 0.613-0.619),Brier评分为0.342(95% CI 0.340-0.347):在这项评估TPE住院患者出血复发预测因素的研究中,我们发现了七个变量和五个交互作用。这些发现应在今后的研究中加以验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Blood Transfusion
Blood Transfusion HEMATOLOGY-
CiteScore
6.10
自引率
2.70%
发文量
91
审稿时长
2 months
期刊介绍: Blood Transfusion welcomes international submissions of Original Articles, Review Articles, Case Reports and Letters on all the fields related to Transfusion Medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信